Ha seleccionado la visión en Inglés
| Descriptor en español: |
Receptores de Complemento 3d
| ||||||
| Descriptor en inglés: | Receptors, Complement 3d | ||||||
| Descriptor en portugués: | Receptores de Complemento 3d | ||||||
| Descriptor en francés: | Récepteurs au C3d du complément | ||||||
| Término(s) alternativo(s): |
Antigen, CD21 Antigens, CD 21 Antigens, CD21 C3d Receptors CD 21 Antigens CD21 Antigen CD21 Antigens CR2 Receptors Complement 3d Receptor Complement 3d Receptors Complement Receptor 2 Complement Receptors 2 Epstein Barr Virus Receptor Epstein Barr Virus Receptors Epstein-Barr Virus Receptor Epstein-Barr Virus Receptors Herpesvirus 4 Receptors, Human Receptor 2, Complement Receptor, Complement 3d Receptor, Epstein-Barr Virus Receptors 2, Complement Receptors, C3d Receptors, CR2 Receptors, Epstein Barr Virus Receptors, Epstein-Barr Virus Virus Receptor, Epstein-Barr Virus Receptors, Epstein-Barr |
||||||
| Código(s) jeráquico(s): |
D12.776.543.750.705.833.610 D12.776.543.750.830.250 |
||||||
| Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D017464 | ||||||
| Nota de alcance: | Molecular sites on or in B-lymphocytes, follicular dendritic cells, lymphoid cells, and epithelial cells that recognize and combine with COMPLEMENT C3D. Human complement receptor 2 (CR2) serves as a receptor for both C3dg and the gp350/220 glycoprotein of HERPESVIRUS 4, HUMAN, and binds the monoclonal antibody OKB7, which blocks binding of both ligands to the receptor. |
||||||
| Calificadores permitidos: |
AD administration & dosage AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CH chemistry CL classification DE drug effects DF deficiency GE genetics HI history IM immunology IP isolation & purification ME metabolism PH physiology RE radiation effects TU therapeutic use UL ultrastructure |
||||||
| Indexación anterior: |
Antigens, Differentiation, B-Lymphocyte (1988-1992) Receptors, Complement (1981-1992) |
||||||
| Nota Pública de MeSH: | 1993; EPSTEIN-BARR VIRUS RECEPTOR was indexed under RECEPTORS, VIRUS 1981-98; RECEPTORS, COMPLEMENT 3D was indexed under RECEPTORS, COMPLEMENT and ANTIGENS 1981-92, and under DIFFERENTIATION, B-LYMPHOCYTE 1988-92 |
||||||
| Nota de historia: | 1993 |
||||||
| Versión alternativa: | RECEPT C 3D |
||||||
| Identificador de DeCS: | 30569 | ||||||
| ID del Descriptor: | D017464 | ||||||
| Documentos indizados en la Biblioteca Virtual de Salud (BVS): | Haga clic aquí para acceder a los documentos de la BVS | ||||||
| Fecha de establecimiento: | 01/01/1993 | ||||||
| Fecha de entrada: | 03/06/1992 | ||||||
| Fecha de revisión: | 24/05/2017 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
|
Receptors, Complement 3d
- Concepto preferido
| UI del concepto |
M0026498 |
| Nota de alcance | Molecular sites on or in B-lymphocytes, follicular dendritic cells, lymphoid cells, and epithelial cells that recognize and combine with COMPLEMENT C3D. Human complement receptor 2 (CR2) serves as a receptor for both C3dg and the gp350/220 glycoprotein of HERPESVIRUS 4, HUMAN, and binds the monoclonal antibody OKB7, which blocks binding of both ligands to the receptor. |
| Término preferido | Receptors, Complement 3d |
| Término(s) alternativo(s) |
Antigen, CD21 Antigens, CD 21 Antigens, CD21 C3d Receptors CD 21 Antigens CD21 Antigen CD21 Antigens CR2 Receptors Complement 3d Receptor Complement 3d Receptors Complement Receptor 2 Complement Receptors 2 Epstein Barr Virus Receptor Epstein Barr Virus Receptors Epstein-Barr Virus Receptor Epstein-Barr Virus Receptors Herpesvirus 4 Receptors, Human Receptor 2, Complement Receptor, Complement 3d Receptor, Epstein-Barr Virus Receptors 2, Complement Receptors, C3d Receptors, CR2 Receptors, Epstein Barr Virus Receptors, Epstein-Barr Virus Virus Receptor, Epstein-Barr Virus Receptors, Epstein-Barr |
Queremos sus comentarios sobre el nuevo sitio web de DeCS / MeSH
Lo invitamos a completar una encuesta que no tomará más de 3 minutos.
Ir a la encuesta
